Samantha McLemore’s Illumina ILMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$60.7M Sell
345,314
-199,466
-37% -$29.2M 1.99% 23
2026
Q1
$67.1M Sell
544,780
-30,988
-5% -$4.07M 2.46% 20
2025
Q4
$75.5M Sell
575,768
-5,591
-1% -$656K 2.91% 15
2025
Q3
$55.2M Sell
581,359
-831
-0.1% -$82.4K 2.21% 23
2025
Q2
$55.5M Buy
582,190
+123,521
+27% +$10M 2.51% 21
2025
Q1
$36.4M Buy
458,669
+48,714
+12% +$5.27M 1.87% 26
2024
Q4
$54.8M Sell
409,955
-1,600
-0.4% -$228K 2.53% 23
2024
Q3
$53.7M Sell
411,555
-3,303
-0.8% -$407K 2.64% 19
2024
Q2
$43.3M Buy
414,858
+162,703
+65% +$18.3M 2.3% 22
2024
Q1
$33.7M Buy
252,155
+4,738
+2% +$635K 1.64% 30
2023
Q4
$33.5M Buy
+247,417
New +$28.5M 1.78% 29

Other funds holding ILMN

Samantha McLemore's ILMN Position: Q2 2026 in Review

Samantha McLemore reduced its Illumina (ILMN) stake by 37% in Q2 2026, selling an estimated $29.2M and leaving 345,314 shares worth $60.7M. The position accounts for 1.99% of the portfolio, ranked #23.

Samantha McLemore first reported a position in ILMN in Q4 2023 and has held it in 11 quarters since. The position peaked at $75.5M in Q4 2025. 932 funds tracked by Wall St. Rank hold ILMN as of Q2 2026.

  • Samantha McLemore held 345,314 shares of Illumina worth $60.7M as of Q2 2026.
  • Samantha McLemore sold 199,466 Illumina shares in Q2 2026, an estimated $29.2M.
  • Illumina made up 1.99% of Samantha McLemore's portfolio in Q2 2026, its #23 holding.
  • Samantha McLemore first reported a position in Illumina in Q4 2023 and has held it in 11 quarters since.
  • Samantha McLemore's Illumina position peaked at $75.5M in Q4 2025.
  • 932 funds tracked by Wall St. Rank held Illumina as of Q2 2026.

Based on Patient Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.